2025 ITE TEST
A 67-year-old male sees you for a A) No additional testing for stroke risk
Medicare annual wellness visit. He tells
you that his best friend had a stroke and
he asks about his risk for stroke. He has
no history of stroke, TIA, or neurologic
symptoms. He has a family history of
cardiovascular disease in his father, who
had a myocardial infarction at age 65
and died from a thrombotic stroke at age
71. The patient exercises regularly and
has a BMI of 27 kg/m2. His only current
medical condition is hyperlipidemia, and
his cholesterol level is at goal on
rosuvastatin (Crestor), 10 mg daily. He
also takes aspirin, 81 mg daily. His blood
pressure is 125/78 mm Hg.
Based on U.S. Preventive Services Task
Force guidelines, which one of the
following would be most appropriate at
this time?
A) No additional testing for stroke risk
B) Auscultation for carotid bruits
C) Carotid duplex ultrasonography
, ) p g p y 2025 ITE TEST
D) Magnetic resonance angiography
E) CT angiography of the carotid arter
A 28-year-old female presents for B) Intranasal corticosteroid monotherapy
evaluation of nasal congestion, sneezing,
watery eyes, and postnasal drip. This has
been an intermittent issue for her every
spring and she would like to manage it
more effectively.
Which one of the following treatments
has been shown to be the most effective
and best tolerated first-line therapy for
this patient's condition?
A) A leukotriene receptor antagonist
B) Intranasal corticosteroid
monotherapy
C) Intranasal corticosteroids plus an oral
antihistamine
D) Inhaled corticosteroids
E) Annual triamcinolone injections
, 2025 ITE TEST
A 68-year-old female presents with a 2- B) Colonoscopy
month history of watery diarrhea. She
has not had any blood or pus in her
stools, and the stools are not oily. She
has not had any history of fever, chills, or
weight loss, and has not traveled
recently. She smokes one pack of
cigarettes per day. Her medications
include ibuprofen, sertraline (Zoloft),
and pantoprazole (Protonix). A CBC,
metabolic panel, C-reactive protein
level, IgA anti-tissue transglutaminase
level, total IgA level, and stool guaiac
test are all normal.
Which one of the following tests would
be most likely to yield a diagnosis?
A) Clostridioides (Clostridium) difficile
toxin
B) Colonoscopy
C) Fecal calprotectin
D) A stool culture
E) Stool examination for ova and
parasites
, 2025 ITE TEST
A 23-year-old male with opioid use C) 8-12 hours after his last opioid use
disorder requests buprenorphine
therapy. He is still actively using
immediate-release oxycodone
(Roxicodone) and he took a dose 2
hours ago.
This patient should begin buprenorphine
induction
A) now
B) in 2 hours
C) 8-12 hours after his last opioid use
D) 24 hours after his last opioid use
E) 1 week after his last opioid use
A 67-year-old male sees you for a A) No additional testing for stroke risk
Medicare annual wellness visit. He tells
you that his best friend had a stroke and
he asks about his risk for stroke. He has
no history of stroke, TIA, or neurologic
symptoms. He has a family history of
cardiovascular disease in his father, who
had a myocardial infarction at age 65
and died from a thrombotic stroke at age
71. The patient exercises regularly and
has a BMI of 27 kg/m2. His only current
medical condition is hyperlipidemia, and
his cholesterol level is at goal on
rosuvastatin (Crestor), 10 mg daily. He
also takes aspirin, 81 mg daily. His blood
pressure is 125/78 mm Hg.
Based on U.S. Preventive Services Task
Force guidelines, which one of the
following would be most appropriate at
this time?
A) No additional testing for stroke risk
B) Auscultation for carotid bruits
C) Carotid duplex ultrasonography
, ) p g p y 2025 ITE TEST
D) Magnetic resonance angiography
E) CT angiography of the carotid arter
A 28-year-old female presents for B) Intranasal corticosteroid monotherapy
evaluation of nasal congestion, sneezing,
watery eyes, and postnasal drip. This has
been an intermittent issue for her every
spring and she would like to manage it
more effectively.
Which one of the following treatments
has been shown to be the most effective
and best tolerated first-line therapy for
this patient's condition?
A) A leukotriene receptor antagonist
B) Intranasal corticosteroid
monotherapy
C) Intranasal corticosteroids plus an oral
antihistamine
D) Inhaled corticosteroids
E) Annual triamcinolone injections
, 2025 ITE TEST
A 68-year-old female presents with a 2- B) Colonoscopy
month history of watery diarrhea. She
has not had any blood or pus in her
stools, and the stools are not oily. She
has not had any history of fever, chills, or
weight loss, and has not traveled
recently. She smokes one pack of
cigarettes per day. Her medications
include ibuprofen, sertraline (Zoloft),
and pantoprazole (Protonix). A CBC,
metabolic panel, C-reactive protein
level, IgA anti-tissue transglutaminase
level, total IgA level, and stool guaiac
test are all normal.
Which one of the following tests would
be most likely to yield a diagnosis?
A) Clostridioides (Clostridium) difficile
toxin
B) Colonoscopy
C) Fecal calprotectin
D) A stool culture
E) Stool examination for ova and
parasites
, 2025 ITE TEST
A 23-year-old male with opioid use C) 8-12 hours after his last opioid use
disorder requests buprenorphine
therapy. He is still actively using
immediate-release oxycodone
(Roxicodone) and he took a dose 2
hours ago.
This patient should begin buprenorphine
induction
A) now
B) in 2 hours
C) 8-12 hours after his last opioid use
D) 24 hours after his last opioid use
E) 1 week after his last opioid use
